Healthcare Stocks
Why Moderna (NASDAQ:MRNA) Stock Jumped 14% to a 52-Week High: Nasdaq-100 (NDX) Return and NIH Cancer Vaccine Push Explained
Index-fund buying and a national cancer vaccine plan landed on the same day, lifting a stock that has already run more than 600% this year
Penny Stock Watch: Milestone Jumps While XORTX, bioAffinity Tumble Today
Four small healthcare and biotech penny stocks, all trading under USD 5, made sharp moves today on clinical trial news, a stock offering, and a steep selloff.
FDA Approvals and Trial Results: Teva, Natera, Glaukos Stocks Surge Today
Four healthcare companies delivered major regulatory and clinical news today, covering cancer screening, eye surgery, mental health treatment, and a rare disease drug.
Fall Clinical Dermatology Conference 2026: Lilly, J&J, Arcutis, Alumis, Sagimet Stocks Jump on New Data
Five healthcare companies updated the market this week with fresh psoriasis and acne data from a major dermatology conference, and their stocks reacted fast.
8 Penny Stocks in Focus: What's Behind the Plunge in China SXT, Sunshine Biopharma, and Medicus Pharma
Eight penny stocks posted unusually large price swings today, with new financing rounds driving the steepest declines in China SXT, Sunshine Biopharma, and Medicus Pharma.
.png)
Which Biotech Stocks Moved Today and Why? Viatris, Pacira, Bristol-Myers, argenx, and 13 More on October 8, 2026
Seventeen biotech companies posted notable news today, ranging from a USD 1.65 billion acquisition to sharp swings in smaller, lower-priced stocks.
Why Did China SXT Pharmaceuticals (Nasdaq:SXTC) Stock Spike 65% After Hours?
Small stocks, wide spreads, no news: China SXT Pharmaceuticals (Nasdaq:SXTC) rose about 65% after hours, which says less about pharmaceuticals than about how little it takes to move a very small share price
Why Did Option Care Health (Nasdaq:OPCH) Stock Surge 33% on the McKesson Deal?
Nothing lifts a share price like a buyer with a chequebook. Option Care Health (Nasdaq:OPCH) closed 33% higher after McKesson and a private-equity partner offered $32.05 a share, leaving little room for after-hours drama.
Why Did Neogen (Nasdaq:NEOG) Stock Rise After Hours?
A loss on paper, a profit by adjustment and a beaten-down share price: Neogen (Nasdaq:NEOG) rose about 9% after hours as a food-safety beat gave the market a reason to exhale.
Why Did Caribou Biosciences (Nasdaq:CRBU) Stock Plunge After Hours?
Biotech investors know the arithmetic of a failed pipeline. Caribou Biosciences (Nasdaq:CRBU) shed up to 46% after hours once its two CAR-T programs were scrapped, leaving a cash balance, a banker and a lot of hope.
Trending topics
Recent post
Betting Against the Buildout: Inver...
The Wall Street Wrap: October 16, 2...
Oil Beats Silicon: TSX Edges Higher...
The Patient Hinge: iPhone Duo - Why...
